For sponsors, improving oversight of study startup means real-time visibility into the progress of studies outsourced to their CRO partners, and transitioning away from tactical projects toward strategic partnerships, with both stakeholders having a vested interest.
Oracle Analyze Insight for Activate Cloud Service intelligence improves transparency, communication, and collaboration with CROs by providing sponsors with timely status updates and operational insights into outsourced studies with their CRO partners, leading to enhanced performance and governance. Through visually rich analytics and dashboards, we help transition your team from a process that is reactive to one that is more proactive.
Learn the importance of this regulation and its impact on large multi-country studies.
Learn how decentralized clinical trials have forced the industry to rethink their approach to study startup and associated regulations.
Learn how the traditional steps needed to start clinical trials need to be expanded upon, collapsed, and fit for purpose.
The way clinical trials are conducted in the European Union will undergo a major change when this regulation comes into effect in January 2022, which is binding across all member states.
As CROs fight to maintain market share and ensure long-term survival, those capable of critical thinking and proactive planning may be well-positioned to reap the rewards.
Learn about forthcoming guidance which renews the focus on efficiencies in conducting clinical trials and provide tools to do so - significantly impacting oversight.
Learn how Pfizer successfully brought a highly effective and safe COVID-19 vaccine to market in under a year, and how these same breakthroughs could be applied to other studies.
Learn how trusted collaboration is key to keeping sponsor-CRO partnerships aligned on shared goals.